サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：タンパク質発現市場：産業動向と世界予測 (～2035年) - タンパク質発現システムタイプ別、タンパク質発現関連オファリング別、応用分野別、エンドユーザー別、運用タイプ別、地域別、主要企業
市場調査レポート
商品コード
1549404

タンパク質発現市場：産業動向と世界予測 (～2035年) - タンパク質発現システムタイプ別、タンパク質発現関連オファリング別、応用分野別、エンドユーザー別、運用タイプ別、地域別、主要企業

Protein Expression Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Type of Protein Expression System, Protein Expression-related Offerings, Application Area, End-users, Type of Operation, Geography and Key Players
出版日: | 発行: Roots Analysis | ページ情報: 英文 165 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.72円
タンパク質発現市場：産業動向と世界予測 (～2035年) - タンパク質発現システムタイプ別、タンパク質発現関連オファリング別、応用分野別、エンドユーザー別、運用タイプ別、地域別、主要企業
出版日: 2024年07月01日
発行: Roots Analysis
ページ情報: 英文 165 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

タンパク質発現の市場規模は、2024年に27億米ドルになるとみられ、予測期間の2024年～2035年のCAGRは8％と見込まれています。

アミノ酸の長い鎖で構成されるタンパク質は、新薬、治療、診断ツールの開発においてますます重要性を増しています。多用途性、代謝安定性、標的特異性、高い親和性により、治療用途として魅力的な候補となっています。実際、2023年のトップセラー医薬品の50％はタンパク質ベースの治療薬であり、がん、免疫疾患、感染症、糖尿病など様々な慢性疾患の治療薬として米国FDAに承認された治療薬は20を超えます。さらに、2023年以降、タンパク質発現に関連する6,500件以上の特許が付与されています。

タンパク質治療薬に対する需要の高まりと革新的な生産方法の必要性により、製薬会社は組換えタンパク質の生産にタンパク質発現システムを採用するようになっています。これらのシステムは、幅広い標的分子を生産できること、収率が高いこと、開発期間が短いこと、生産コストが低いことなど、いくつかの利点を提供しています。さらに、各社はタンパク質発現のためのキットや試薬を開発し、毒性タンパク質、膜タンパク質、翻訳後修飾タンパク質を含む複雑なタンパク質の合成を可能にしています。

慢性疾患の罹患率が上昇を続ける中、タンパク質治療薬に対する需要は増加すると思われます。タンパク質ベースのリード化合物の臨床試験および商業化への成熟と、発現システムの進歩が、予測期間中のタンパク質発現市場の成長を促進すると予想されます。

当レポートでは、世界のタンパク質発現市場について調査し、市場の概要とともに、タンパク質発現システムタイプ別、タンパク質発現関連オファリング別、応用分野別、エンドユーザー別、運用タイプ別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 序文

第2章 調査手法

第3章 経済およびその他のプロジェクト特有の考慮事項

第4章 エグゼクティブサマリー

第5章 イントロダクション

第6章 市場情勢：主要なタンパク質発現プロバイダー

  • 主要なタンパク質発現プロバイダー：全体的な市場情勢

第7章 企業競争力分析：主要なタンパク質発現プロバイダー

  • 主要なパラメータと調査手法
  • 企業競争力分析：タンパク質発現プロバイダー：
  • タンパク質発現プロバイダー：主要参入企業のベンチマーク分析

第8章 企業プロファイル

  • Agilent Technologies
  • Ajinomoto Bio-Pharma Services
  • Charles River Laboratories
  • GenScript Biotech
  • Lonza
  • Merck
  • QIAGEN
  • Sartorius
  • Thermo Fisher Scientific
  • WuXi Biologics
  • その他

第9章 バリューチェーン分析

第10章 市場への影響分析：促進要因、抑制要因、機会、課題

第11章 世界のタンパク質発現市場

第12章 タンパク質発現市場、タンパク質発現システムタイプ別

第13章 タンパク質発現市場、タンパク質発現関連オファリング別

第14章 タンパク質発現市場、応用分野別

第15章 タンパク質発現市場、エンドユーザー別

第16章 タンパク質発現市場、運用タイプ別

第17章 タンパク質発現市場、地域別

第18章 タンパク質発現市場、主要企業別

第19章 エグゼクティブ洞察

第20章 付録1：表形式のデータ

第21章 付録2：企業・団体一覧

図表

List of Tables

  • Table 5.1 Types of Protein Expression Systems
  • Table 6.1 List of Companies Offering Protein Expression
  • Table 20.1 Protein Expression Providers: Distribution by Year of Establishment
  • Table 20.2 Protein Expression Providers: Distribution by Company Size
  • Table 20.3 Protein Expression Providers: Distribution by Location of Headquarters (Region)
  • Table 20.4 Protein Expression Providers: Distribution by Location of Headquarters (Country)
  • Table 20.5 Protein Expression: Distribution by Type of Protein Expression System
  • Table 20.6 Protein Expression: Distribution by Protein Expression-related Offerings
  • Table 20.7 Protein Expression: Distribution by Application Area
  • Table 20.8 Agilent Technologies: Financial Information (USD Billion)
  • Table 20.9 Ajinomoto Bio-Pharma Services: Financial Information (YEN Billion)
  • Table 20.10 Charles River Laboratories: Financial Information (USD Billion)
  • Table 20.11 GenScript Biotech: Financial Information (USD Million)
  • Table 20.12 Lonza: Financial Information (CHF Billion)
  • Table 20.13 Merck: Financial Information (EUR Billion)
  • Table 20.14 QIAGEN: Financial Information (USD Billion)
  • Table 20.15 Sartorius: Financial Information (EUR Billion)
  • Table 20.16 Thermo Fisher Scientific: Financial Information (USD Billion)
  • Table 20.17 WuXi Biologics: Financial Information (RMB Billion)
  • Table 20.18 Global Protein Expression Market, Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Billion)
  • Table 20.19 Global Protein Expression Market, Forecasted Estimates (2024-2035): Conservative Scenario (USD Billion)
  • Table 20.20 Global Protein Expression Market, Forecasted Estimates (2024-2035): Optimistic Scenario (USD Billion)
  • Table 20.21 Global Protein Expression Market: Distribution by Type of Protein Expression System, 2020, 2024 and 2035 (USD Million)
  • Table 20.22 Protein Expression Market for Mammalian Expression System: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.23 Protein Expression Market for Prokaryotic Expression System: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.24 Protein Expression Market for Yeast Expression System: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.25 Protein Expression Market for Insect Expression System: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.26 Protein Expression Market for Cell-free Expression System: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.27 Protein Expression Market for Algal Expression System: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.28 Global Protein Expression Market: Distribution by Protein Expression-related Offerings, 2020, 2024 and 2035(USD Million)
  • Table 20.29 Protein Expression Market for Kits and Reagents: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.30 Protein Expression Market for Protein Expression Services: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.31 Protein Expression Market for Instruments: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.32 Protein Expression Market for Competent Cells: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.33 Protein Expression Market for Expression Vectors: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.34 Global Protein Expression Market: Distribution by Application Area, 2020, 2024 and 2035 (USD Million)
  • Table 20.35 Protein Expression Market for Therapeutics: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.36 Protein Expression Market for Research and Diagnostics: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.37 Global Protein Expression Market: Distribution by End-users, 2020, 2024 and 2035 (USD Million)
  • Table 20.38 Protein Expression Market for Pharmaceutical and Biotechnology Companies: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.39 Protein Expression Market for CROs and CDMOs: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.40 Protein Expression Market for Academic and Research Institutes: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.41 Protein Expression Market for Other End-users: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.42 Global Protein Expression Market: Distribution by Type of Operation, 2020, 2024 and 2035(USD Million)
  • Table 20.43 Protein Expression Market for In-house Operations: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.44 Protein Expression Market for Outsourced Operations: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.45 Global Protein Expression Market: Distribution by Geography, 2020, 2024 and 2035 (USD Million)
  • Table 20.46 Protein Expression Market in North America: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.47 Protein Expression Market in the US: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.48 Protein Expression Market in Canada: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.49 Protein Expression Market in Europe: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.50 Protein Expression Market in Germany: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.51 Protein Expression Market in France: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.52 Protein Expression Market in Italy: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.53 Protein Expression Market in the UK: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.54 Protein Expression Market in Spain: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.55 Protein Expression Market in Rest of Europe: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.56 Protein Expression Market in Asia-Pacific, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Million)
  • Table 20.57 Protein Expression Market in China, Historical Trends (2018-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.58 Protein Expression Market in Japan, Historical Trends (2018-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.59 Protein Expression Market in South Korea, Historical Trends (2018-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.60 Protein Expression Market in India, Historical Trends (2018-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.61 Protein Expression Market in Rest of Asia-Pacific, Historical Trends (2018-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.62 Protein Expression Market in Latin America, Historical Trends (2018-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Table 20.63 Protein Expression Market in Middle East and North Africa, Historical Trends (2018-2023) and Forecasted Estimates (2024-2035) (USD Million)

List of Figures

  • Figure 2.1 Research Methodology: Research Assumptions
  • Figure 2.2 Research Methodology: Project Methodology
  • Figure 2.3 Research Methodology: Forecast Methodology
  • Figure 2.4 Research Methodology: Robust Quality Control
  • Figure 2.5 Research Methodology: Key Market Segmentations
  • Figure 4.1 Executive Summary: Market Landscape of Key Players
  • Figure 4.2 Market Sizing and Opportunity Analysis
  • Figure 5.1 Schematic Representation of Protein Expression Process
  • Figure 5.2 Challenges in Protein Expression
  • Figure 6.1 Protein Expression Providers: Distribution by Year of Establishment
  • Figure 6.2 Protein Expression Providers: Distribution by Company Size
  • Figure 6.3 Protein Expression Providers: Distribution by Location of Headquarters (Region)
  • Figure 6.4 Protein Expression Providers: Distribution by Location of Headquarters (Country)
  • Figure 6.5 Protein Expression: Distribution by Type of Protein Expression System
  • Figure 6.6 Protein Expression: Distribution by Protein Expression-related Offerings
  • Figure 6.7 Protein Expression: Distribution by Application Area
  • Figure 7.1 Protein Expression Providers: 3-D Bubble Chart
  • Figure 7.2 Spider Web Analysis: Agilent Technologies
  • Figure 7.3 Spider Web Analysis: Ajinomoto Bio-Pharma Services
  • Figure 7.4 Spider Web Analysis: Charles River Laboratories
  • Figure 7.5 Spider Web Analysis: GenScript Biotech
  • Figure 7.6 Spider Web Analysis: Lonza
  • Figure 7.7 Spider Web Analysis: Merck
  • Figure 7.8 Spider Web Analysis: QIAGEN
  • Figure 7.9 Spider Web Analysis: Sartorius
  • Figure 7.10 Spider Web Analysis: Thermo Fisher Scientific Competitiveness
  • Figure 7.11 Spider Web Analysis: WuXi Biologics
  • Figure 7.12 Parameter-wise Benchmarking: By Years of Experience
  • Figure 7.13 Parameter-wise Benchmarking: By Company Size
  • Figure 7.14 Parameter-wise Benchmarking: By Annual Revenues
  • Figure 7.15 Parameter-wise Benchmarking: By Type of Protein Expression System
  • Figure 7.16 Parameter-wise Benchmarking: By Number of Protein Expression-related Offerings
  • Figure 7.17 Parameter-wise Benchmarking: By Number of Application Areas
  • Figure 8.1 Agilent Technologies: Financial Information (USD Billion)
  • Figure 8.2 Ajinomoto Bio-Pharma Services: Financial Information (YEN Billion)
  • Figure 8.3 Charles River Laboratories: Financial Information (USD Billion)
  • Figure 8.4 GenScript Biotech: Financial Information (USD Million)
  • Figure 8.5 Lonza: Financial Information (CHF Billion)
  • Figure 8.6 Merck: Financial Information (EUR Billion)
  • Figure 8.7 QIAGEN: Financial Information (USD Billion)
  • Figure 8.8 Sartorius: Financial Information (EUR Billion)
  • Figure 8.9 Thermo Fisher Scientific: Financial Information (USD Billion)
  • Figure 8.10 WuXi Biologics: Financial Information (RMB Billion)
  • Figure 11.1 Global Protein Expression Market, Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Billion)
  • Figure 11.2 Global Protein Expression Market, Forecasted Estimates (2024-2035): Conservative Scenario (USD Billion)
  • Figure 11.3 Global Protein Expression Market, Forecasted Estimates (2024-2035): Optimistic Scenario (USD Billion)
  • Figure 12.1 Global Protein Expression Market: Distribution by Type of Protein Expression System, 2020, 2024 and 2035 (USD Million)
  • Figure 12.2 Protein Expression Market for Mammalian Expression System: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 12.3 Protein Expression Market for Prokaryotic Expression System: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 12.4 Protein Expression Market for Yeast Expression System: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 12.5 Protein Expression Market for Insect Expression System: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 12.6 Protein Expression Market for Cell-free Expression System: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 12.7 Protein Expression Market for Algal Expression System: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 13.1 Global Protein Expression Market: Distribution by Protein Expression-related Offerings, 2020, 2024 and 2035 (USD Million)
  • Figure 13.2 Protein Expression Market for Kits and Reagents: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 13.3 Protein Expression Market for Protein Expression Services: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 13.4 Protein Expression Market for Instruments: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 13.5 Protein Expression Market for Competent Cells: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 13.6 Protein Expression Market for Expression Vectors: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 14.1 Global Protein Expression Market: Distribution by Application Area, 2020, 2024 and 2035 (USD Million)
  • Figure 14.2 Protein Expression Market for Therapeutics: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 14.3 Protein Expression Market for Research and Diagnostics: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 15.1 Global Protein Expression Market: Distribution by End-users, 2020, 2024 and 2035 (USD Million)
  • Figure 15.2 Protein Expression Market for Pharmaceutical and Biotechnology Companies: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 15.3 Protein Expression Market for CROs and CDMOs: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 15.4 Protein Expression Market for Academic and Research Institutes: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 15.5 Protein Expression Market for Other End-users: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 16.1 Global Protein Expression Market: Distribution by Type of Operation, 2020, 2024 and 2035 (USD Million)
  • Figure 16.2 Protein Expression Market for In-house Operations: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 16.3 Protein Expression Market for Outsourced Operations: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 17.1 Global Protein Expression Market: Distribution by Geography, 2020, 2024 and 2035 (USD Million)
  • Figure 17.2 Protein Expression Market in North America: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 17.3 Protein Expression Market in the US: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 17.4 Protein Expression Market in Canada: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 17.5 Protein Expression Market in Europe: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 17.6 Protein Expression Market in Germany: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 17.7 Protein Expression Market in France: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 17.8 Protein Expression Market in Italy: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 17.9 Protein Expression Market in the UK: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 17.10 Protein Expression Market in Spain: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 17.11 Protein Expression Market in Rest of Europe: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 17.12 Protein Expression Market in Asia-Pacific, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Million)
  • Figure 17.13 Protein Expression Market in China, Historical Trends (2018-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 17.14 Protein Expression Market in Japan, Historical Trends (2018-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 17.15 Protein Expression Market in South Korea, Historical Trends (2018-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 17.16 Protein Expression Market in India, Historical Trends (2018-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 17.17 Protein Expression Market in Rest of Asia-Pacific, Historical Trends (2018-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 17.18 Protein Expression Market in Latin America, Historical Trends (2018-2023) and Forecasted Estimates (2024-2035) (USD Million)
  • Figure 17.19 Protein Expression Market in Middle East and North Africa, Historical Trends (2018-2023) and Forecasted Estimates (2024-2035) (USD Million)
目次
Product Code: RA100156

The Protein Expression Market is valued at USD 2.7 billion in 2024 growing at a CAGR of 8% during the forecast period 2024-2035.

Proteins, composed of long chains of amino acids, have become increasingly important in the development of new drugs, treatments, and diagnostic tools. Their versatility, metabolic stability, target specificity, and high affinity have made them attractive candidates for therapeutic applications. In fact, 50% of the top-selling drugs in 2023 are protein-based therapeutics, with over 20 such treatments approved by the US FDA for the treatment of various chronic diseases, including cancers, immune disorders, infections, and diabetes. Furthermore, since 2023, over 6,500 patents related to protein expression have been granted.

The growing demand for protein therapeutics and the need for innovative production methods have driven pharmaceutical companies to adopt protein expression systems for the production of recombinant proteins. These systems offer several advantages, including the ability to produce a wide range of target molecules, higher yields, shorter development times, and lower production costs. Additionally, companies have developed kits and reagents for protein expression, enabling the synthesis of complex proteins, including toxic proteins, membrane proteins, and post-translationally modified proteins.

As the incidence of chronic diseases continues to rise, the demand for protein therapeutics is likely to increase. The maturation of protein-based leads into clinical trials and commercialization, as well as advancements in expression systems, are expected to drive the growth of the protein expression market over the forecast period.

Key Market Segments

Type of Protein Expression System

  • Algal Expression Systems
  • Cell-free Expression Systems
  • Insect Expression Systems
  • Mammalian Expression Systems
  • Prokaryotic Expression Systems
  • Yeast Expression Systems

Protein Expression-related Offerings

  • Competent Cells
  • Expression Vectors
  • Instruments
  • Kits and Reagents
  • Protein Expression Services

Application Area

  • Research and Diagnostics
  • Therapeutics

End Users

  • Academic and Research Institutes
  • CROs and CDMOs
  • Pharmaceutical and Biotechnology Companies
  • Other End-users

Type of Operation

  • In-house Operations
  • Outsourced Operations

Geography

  • North America (US and Canada)
  • Europe (France, Germany, Italy, Spain, UK and Rest of Europe)
  • Asia-Pacific (India, China, Japan, South Korea and Rest of Asia-Pacific)
  • Latin America
  • Middle East and North Africa

Research Coverage:

  • This report provides a comprehensive introduction to protein expression, including its process and various applications. It explores different types of expression systems, their key features, and uses. Additionally, it discusses challenges and recent trends in protein expression, providing insights for researchers and industry professionals.
  • A comprehensive assessment of protein expression product and service providers, along with information on several relevant parameters, such as year of establishment, company size (in terms of employee count) and location of headquarters (region and country), type of protein expression systems (algal, cell-free, insect, mammalian, prokaryotic and yeast expression systems), protein expression-related offerings (competent cells, expression vectors, instruments, kits and reagents and protein expression services) and application areas (industrial, research and therapeutic).
  • This report provides a comprehensive competitiveness analysis of protein expression product and service providers. Key parameters considered include developer strength (company size and experience) and portfolio strength (type of protein expression systems, offerings, and application areas). The report also conducts a benchmarking analysis, highlighting the focus areas of companies and comparing their capabilities among competitors. This analysis provides valuable insights into the strengths and weaknesses of leading protein expression providers, enabling informed decision-making.
  • This report provides in-depth profiles of key companies in the protein expression market. Each profile includes a brief overview, protein expression offerings, financial information, recent developments, and a future outlook. This comprehensive analysis helps readers understand the market dynamics, company strengths, and growth prospects.
  • This report provides an in-depth analysis of the protein expression value chain, including supplier-end user relationships and process stages from design to large-scale production.
  • This report examines the protein expression market's growth drivers, restraints, emerging opportunities, and existing challenges, providing a comprehensive analysis of the factors influencing the market's trajectory.
  • This report provides a detailed estimate of the current market size and future growth potential of the protein expression market from 2024 to 2035. Our analysis is based on adoption trends, secondary and primary research, and reliable data. We have also provided a breakdown of the current and forecasted opportunity within the protein expression industry. To account for future uncertainties, we have developed three forecast scenarios: conservative, base, and optimistic, representing different market growth tracks. These scenarios provide a robust outlook for the market, allowing stakeholders to plan and prepare for various possibilities.
  • Comprehensive prediction of the current and future opportunity within protein expression market across different types of protein expression systems, such as algal, cell-free, insect, mammalian, prokaryotic and yeast expression systems.
  • Detailed predictions of the current and future opportunity within protein expression domain across various protein expression-related offerings, such as competent cells, expression vectors, instruments, kits and reagents and protein expression services.
  • Comprehensive assessment of the current and future opportunity within protein expression industry across various application areas, such as research and diagnostics, and therapeutics.
  • Comprehensive projections of the current and future opportunity within protein expression market across different end-users, such as academic and research institutes, CROs and CDMOs, pharmaceutical and biotechnology companies and other end-users.
  • Comprehensive prediction of the current and future opportunity within the market for protein expression across different types of operation, such as in-house operations and outsourced operations.
  • Comprehensive projections of the current and future opportunity within protein expression market across various geographies, such as North America (US and Canada), Europe (France, Germany, Italy, Spain, UK and Rest of Europe), Asia-Pacific (India, China, Japan, South Korea and Rest of Asia-Pacific), Latin America and Middle East and North Africa.
  • In-depth discussion on the leading protein expression product and service providers in this industry, highlighting their protein expression portfolio and annual revenues of business segment that includes protein expression.

Key Benefits of Buying this Report

  • The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
  • Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
  • The report provides stakeholders with a pulse on the Protein Expression Market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Leading Market Companies

  • Agilent Technologies
  • Ajinomoto Bio-Pharma Services
  • Aldevron
  • Cayman Chemical
  • Charles River Laboratories
  • Domainex
  • Eurofins CALIXAR
  • GeNext Genomics
  • GenScript Biotech
  • Lonza
  • Merck KGaA
  • New England Biolabs
  • ProMab
  • Promega
  • ProteoGenix

QIAGEN

  • Sartorius
  • Synbio Technologies
  • Syngene
  • Takara Bio
  • Thermo Fisher Scientific
  • WuXi Biologics

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Introduction
  • 1.2. Market Share Insights
  • 1.3. Key Market Insights
  • 1.4. Report Coverage
  • 1.5. Key Questions Answered
  • 1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

  • 2.1. Chapter Overview
  • 2.2. Research Assumptions
  • 2.3. Project Methodology
  • 2.4. Forecast Methodology
  • 2.5. Robust Quality Control
  • 2.6. Key Market Segmentations
  • 2.7. Key Considerations
    • 2.7.1. Demographics
    • 2.7.2. Economic Factors
    • 2.7.3. Government Regulations
    • 2.7.4. Supply Chain
    • 2.7.5. COVID Impact
    • 2.7.6. Market Access
    • 2.7.7. Healthcare Policies
    • 2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

  • 3.1. Chapter Overview
  • 3.2. Market Dynamics
    • 3.2.1. Time Period
      • 3.2.1.1. Historical Trends
      • 3.2.1.2. Current and Forecasted Estimates
    • 3.2.2. Currency Coverage and Foreign Exchange Rate
      • 3.2.2.1. Major Currencies Affecting the Market
      • 3.2.2.2. Factors affecting Currency Fluctuations and Foreign Exchange Rates
      • 3.2.2.3. Impact of Foreign Exchange Rate Volatility on Market
      • 3.2.2.4. Strategies For Mitigating Foreign Exchange Risk
    • 3.2.3. Trade Policies
      • 3.2.3.1. Impact of Trade Barriers on the Market
      • 3.2.3.2. Strategies for Mitigating the Risks Associated with Trade Barriers
    • 3.2.4. Recession
      • 3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
      • 3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
    • 3.2.5. Inflation
      • 3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
      • 3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION

  • 5.1. An Overview of Protein Expression
  • 5.2. Schematic Representation of Protein Expression Process
  • 5.3. Applications of Protein Expression
  • 5.4. Types of Protein Expression Systems
  • 5.5. Challenges in Protein Expression
  • 5.6. Recent Trends

6. MARKET LANDSCAPE: KEY PROTEIN EXPRESSION PROVIDERS

  • 6.1. Key Protein Expression Providers: Overall Market Landscape
    • 6.1.1. Analysis by Year of Establishment
    • 6.1.2. Analysis by Company Size
    • 6.1.3. Analysis by Location of Headquarters (Region)
    • 6.1.4. Analysis by Location of Headquarters (Country)
    • 6.1.5. Analysis by Type of Protein Expression System
    • 6.1.6. Analysis by Protein Expression-related Offerings
    • 6.1.7. Analysis by Application Area

7. COMPANY COMPETITIVENESS ANALYSIS: KEY PROTEIN EXPRESSION PROVIDERS

  • 7.1. Key Parameters and Methodology
  • 7.2. Company Competitiveness Analysis: Protein Expression Providers:
  • 7.3. Protein Expression Providers: Benchmarking Analysis of Key Players
    • 7.3.1. Spider Web Analysis: Benchmarking of Key Players
      • 7.3.1.1. Agilent Technologies
      • 7.3.1.2. Ajinomoto Bio-Pharma Services
      • 7.3.1.3. Charles River Laboratories
      • 7.3.1.4. GenScript Biotech
      • 7.3.1.5. Lonza
      • 7.3.1.6. Merck
      • 7.3.1.7. QIAGEN
      • 7.3.1.8. Sartorius
      • 7.3.1.9. Thermo Fisher Scientific
      • 7.3.1.10. WuXi Biologics
    • 7.3.2. Protein Expression Providers: Parameter-wise Benchmarking
      • 7.3.2.1. By Years of Experience
      • 7.3.2.2. By Company Size
      • 7.3.2.3. By Annual Revenues
      • 7.3.2.4. By Type of Protein Expression System
      • 7.3.2.5. By Number of Protein Expression-related Offerings
      • 7.3.2.6. By Number of Application Areas

8. COMPANY PROFILES

  • 8.1. Agilent Technologies
    • 8.1.1. Company Details
    • 8.1.2. Protein Expression-related Offerings
    • 8.1.3. Financial Details
    • 8.1.4. Recent Developments and Future Outlook
  • 8.2. Ajinomoto Bio-Pharma Services
    • 8.2.1. Company Details
    • 8.2.2. Protein Expression-related Offerings
    • 8.2.3. Financial Details
    • 8.2.4. Recent Developments and Future Outlook
  • 8.3. Charles River Laboratories
    • 8.3.1. Company Details
    • 8.3.2. Protein Expression-related Offerings
    • 8.3.3. Financial Details
    • 8.3.4. Recent Developments and Future Outlook
  • 8.4. GenScript Biotech
    • 8.4.1. Company Details
    • 8.4.2. Protein Expression-related Offerings
    • 8.4.3. Financial Details
    • 8.4.4. Recent Developments and Future Outlook
  • 8.5. Lonza
    • 8.5.1. Company Details
    • 8.5.2. Protein Expression-related Offerings
    • 8.5.3. Financial Details
    • 8.5.4. Recent Developments and Future Outlook
  • 8.6. Merck
    • 8.6.1. Company Details
    • 8.6.2. Protein Expression-related Offerings
    • 8.6.3. Financial Details
    • 8.6.4. Recent Developments and Future Outlook
  • 8.7. QIAGEN
    • 8.7.1. Company Details
    • 8.7.2. Protein Expression-related Offerings
    • 8.7.3. Financial Details
    • 8.7.4. Recent Developments and Future Outlook
  • 8.8. Sartorius
    • 8.8.1. Company Details
    • 8.8.2. Protein Expression-related Offerings
    • 8.8.3. Financial Details
    • 8.8.4. Recent Developments and Future Outlook
  • 8.9. Thermo Fisher Scientific
    • 8.9.1. Company Details
    • 8.9.2. Protein Expression-related Offerings
    • 8.9.3. Financial Details
    • 8.9.4. Recent Developments and Future Outlook
  • 8.10. WuXi Biologics
    • 8.10.1. Company Details
    • 8.10.2. Protein Expression-related Offerings
    • 8.10.3. Financial Details
    • 8.10.4. Recent Developments and Future Outlook
  • 8.11. Other Prominent Players
    • 8.11.1. Aldevron
      • 8.11.1.1. Company Details
      • 8.11.1.2. Protein Expression-related Offerings
    • 8.11.2. Cayman Chemical
      • 8.11.2.1. Company Details
      • 8.11.2.2. Protein Expression-related Offerings
    • 8.11.3. Domainex
      • 8.11.3.1. Company Details
      • 8.11.3.2. Protein Expression-related Offerings
    • 8.11.4. Eurofins CALIXAR
      • 8.11.4.1. Company Details
      • 8.11.4.2. Protein Expression-related Offerings
    • 8.11.5. GeNext Genomics
      • 8.11.5.1. Company Details
      • 8.11.5.2. Protein Expression-related Offerings
    • 8.11.6. New England Biolabs
      • 8.11.6.1. Company Details
      • 8.11.6.2. Protein Expression-related Offerings
    • 8.11.7. ProMab Biotechnologies
      • 8.11.7.1. Company Details
      • 8.11.7.2. Protein Expression-related Offerings
    • 8.11.8. Promega
      • 8.11.8.1. Company Details
      • 8.11.8.2. Protein Expression-related Offerings
    • 8.11.9. ProteoGenix
      • 8.11.9.1. Company Details
      • 8.11.9.2. Protein Expression-related Offerings
    • 8.11.10. Synbio Technologies
      • 8.11.10.1. Company Details
      • 8.11.10.2. Protein Expression-related Offerings
    • 8.11.11. Syngene
      • 8.11.11.1. Company Details
      • 8.11.11.2. Protein Expression-related Offerings
    • 8.11.12. Takara Bio
      • 8.11.12.1. Company Details
      • 8.11.12.2. Protein Expression-related Offerings

9. VALUE CHAIN ANALYSIS

  • 9.1. Brief Overview on Protein Expression Process and Stakeholders Involved
  • 9.2. Schematic Representation of Protein Expression from Design to Large Scale Production

10. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

  • 10.1. Market Drivers
  • 10.2. Market Restraints
  • 10.3. Market Opportunities
  • 10.4. Market Challenges

11. GLOBAL PROTEIN EXPRESSION MARKET

  • 11.1. Key Assumptions and Methodology
  • 11.2. Global Protein Expression Market, Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
    • 11.2.1. Scenario Analysis
      • 11.2.1.1. Conservative Scenario
      • 11.2.1.2. Optimistic Scenario

12. PROTEIN EXPRESSION MARKET, BY TYPE OF PROTEIN EXPRESSION SYSTEM

  • 12.1. Key Assumptions and Methodology
  • 12.2. Protein Expression Market: Distribution by Type of Protein Expression System, 2020, 2024 and 2035
    • 12.2.1. Mammalian Expression System: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
    • 12.2.2. Prokaryotic Expression System: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
    • 12.2.3. Yeast Expression System: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
    • 12.2.4. Insect Expression System: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
    • 12.2.5. Cell-free Expression System: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
    • 12.2.6. Algal Expression System: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)

13. PROTEIN EXPRESSION MARKET, BY PROTEIN EXPRESSION-RELATED OFFERINGS

  • 13.1. Key Assumptions and Methodology
  • 13.2. Protein Expression Market: Distribution by Protein Expression-related Offerings, 2020, 2024 and 2035
    • 13.2.1. Kits and Reagents: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
    • 13.2.2. Protein Expression Services: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
    • 13.2.3. Instruments: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
    • 13.2.4. Competent Cells: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
    • 13.2.5. Expression Vectors: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)

14. PROTEIN EXPRESSION MARKET, BY APPLICATION AREA

  • 14.1. Key Assumptions and Methodology
  • 14.2. Protein Expression Market: Distribution by Application Area, 2020, 2024 and 2035
    • 14.2.1. Therapeutics: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
    • 14.2.2. Research and Diagnostics: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)

15. PROTEIN EXPRESSION MARKET, BY END-USERS

  • 15.1. Key Assumptions and Methodology
  • 15.2. Protein Expression Market: Distribution by Type of End-user, 2020, 2024 and 2035
    • 15.2.1. Pharmaceutical and Biotechnology Companies: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
    • 15.2.2. CROs and CDMOs: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
    • 15.2.3. Academic and Research Institutes: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
    • 15.2.4. Other End-users: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)

16. PROTEIN EXPRESSION MARKET, BY TYPE OF OPERATION

  • 16.1. Key Assumptions and Methodology
  • 16.2. Protein Expression Market: Distribution by Type of Operation, 2020, 2024 and 2035
    • 16.2.1. In-house Operations: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
    • 16.2.2. Outsourced Operations: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)

17. PROTEIN EXPRESSION MARKET, BY GEOGRAPHY

  • 17.1. Key Assumptions and Methodology
  • 17.2. Protein Expression Market: Distribution by Geography, 2020, 2024 and 2035
    • 17.2.1. North America: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
      • 17.2.1.1. US: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
      • 17.2.1.2. Canada: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
    • 17.2.2. Europe: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
      • 17.2.2.1. Germany: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
      • 17.2.2.2. France: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
      • 17.2.2.3. Italy: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
      • 17.2.2.4. UK: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
      • 17.2.2.5. Spain: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
      • 17.2.2.6. Rest of Europe: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
    • 17.2.3. Asia-Pacific: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
      • 17.2.3.1. China: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
      • 17.2.3.2. Japan: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
      • 17.2.3.3. South Korea: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
      • 17.2.3.4. India: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
      • 17.2.3.5. Rest of Asia-Pacific: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
    • 17.2.4. Latin America: Historical Trends (2020-2023) and Future Estimates (2024-2035)
    • 17.2.5. Middle East and North Africa: Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)

18. PROTEIN EXPRESSION MARKET, BY KEY PLAYERS

  • 18.1. Agilent Technologies
  • 18.2. Ajinomoto Bio-Pharma Services
  • 18.3. Charles River Laboratories
  • 18.4. GenScript Biotech
  • 18.5. Lonza
  • 18.6. Merck
  • 18.7. QIAGEN
  • 18.8. Sartorius
  • 18.9. Thermo Fisher Scientific
  • 18.10. WuXi Biologics

19. EXECUTIVE INSIGHTS

20 APPENDIX 1: TABULATED DATA

21 APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS